Carterra

𝗔𝗜 + 𝗛𝗧-𝗦𝗣𝗥 = 𝗔 𝗡𝗲𝘄 𝗘𝗿𝗮 𝗼𝗳 𝗗𝗿𝘂𝗴 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿𝘆!   Carterra is thrilled to partner with innovators at the forefront of drug discovery. 𝗢𝗻𝗲 𝗵𝗼𝘁 𝘁𝗼𝗽𝗶𝗰: 𝗵𝗼𝘄 𝗔𝗜 𝗶𝘀 𝗿𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗶𝘇𝗶𝗻𝗴 𝘁𝗵𝗲 𝘀𝗲𝗮𝗿𝗰𝗵 𝗳𝗼𝗿 𝘁𝗮𝗿𝗴𝗲𝘁𝗲𝗱, 𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲 𝗱𝗿𝘂𝗴 𝗰𝗮𝗻𝗱𝗶𝗱𝗮𝘁𝗲𝘀— 𝗮𝗻𝗱 𝗔𝗯𝘀𝗰𝗶 𝗶𝘀 𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗰𝗵𝗮𝗿𝗴𝗲.   ✨ Check out the latest feature in the International Biopharmaceutical Industry's Autumn 2024 issue to see how Carterra’s HT-SPR technology is helping Absci validate AI models and accelerate high-throughput lead optimization.   https://lnkd.in/d5s_wxhN   #DrugDiscovery #AI #Biotech #Innovation #HTSPR #LSA #Absci

As we approach the close of 2024, we want to express our heartfelt gratitude to our incredible customers, collaborators, and partners for their continued support and engagement with Carterra.   This year has been a tremendous success, and we’re honored to play a part in supporting scientists who are advancing drug discovery and transforming health outcomes worldwide.   From all of us at Carterra, we wish you a joyful end to the year filled with time spent with loved ones. Here’s to an exciting and impactful 2025!   #gratitude #happyholidays #drugdiscovery #Carterra

As we approach the close of 2024, we want to express our heartfelt gratitude to our incredible customers, collaborators, and partners for their continued support and engagement with Carterra.   This year has been a tremendous success, and we’re honored to play a part in supporting scientists who are advancing drug discovery and transforming health outcomes worldwide.   From all of us at Carterra, we wish you a joyful end to the year filled with time spent with loved ones. Here’s to an exciting and impactful 2025!   #gratitude #happyholidays #drugdiscovery #Carterra

Fragment-Based Screening is usually performed on only one or two targets at a time.  High-throughput SPR can increase that to over 100 simultaneous screens providing high-definition data and faster decision making.    Our latest poster, in collaboration with Carna Biosciences, Inc., shows how combining Carterra SPR arrays with an off-the-shelf biotinylated kinase panel enabled collection of 125,000 unique fragment/protein interactions in just three days. This binding and selectivity data can be used early in the drug discovery process to help identify off-target toxicity for this class of targets.   We presented this poster at the recent Drug Discovery Chemistry in Barcelona. If you missed it, check it out here: https://lnkd.in/dygVYTsa   #fragmentscreening #kinases #HTSPR #labelfree #drugdiscovery #DDCEurope

The Carterra LSA-XT high-throughput SPR platform measures binding profiles directly from crude samples—no purification required!    Come see us at AET in San Diego and learn how to analyze up to 1,152 clones in 10 hours with unmatched sensitivity, even for low-expression clones.   #AntibodyScreening #kinetics #SPR #LSAXT #AET2024

Ready to become a leader in SPR assays and analysis? Join us at SPR Camp! This hands-on, two-day program is designed for scientists eager to sharpen their skills in SPR. Designed for both seasoned researchers and those seeking to enhance their SPR expertise, this training provides advanced guidance, actionable strategies, and deep insights to elevate your research outcomes. 📆 Sign up now and secure your spot at one of three locations: https://lnkd.in/g2PrurCy #SPR #HTSPR #Carterra #kinetics

How can you generate data for 125,000 interactions from a fragment-based or target-focused small-molecule library…in just three days?  Find out in our free webinar on December 11, 2024, to be hosted in collaboration with Carna Biosciences, Inc..   HT-SPR is a direct, label-free method that produces gold-standard, real-time kinetics for highly parallel interactions. In this webinar, we highlight the power of combining an extensive panel of biotinylated kinases with small-molecule fragment and target-focused libraries to generate a wealth of compound binding information that can augment the drug discovery process for this challenging class of drug targets.   ➡ Register here and save your spot: https://bit.ly/3AlmBSQ   #HTSPR #kinases #drugdiscovery #labelfree #webinar #smallmolecule #Carterra

🎉 New Webinar On-Demand! 🎉 Our recent webinar, “Discovery, Characterization, and Generative Deep Learning-Based Humanization of Therapeutic Antibody Candidates,” resonated with antibody discovery scientists worldwide.   The session dives into how the powerful synergy between Carterra, Genovac, and ENPICOM platforms accelerates antibody discovery while minimizing risk.   Enhance your antibody discovery journey and unlock insights for generating high-affinity, high-quality antibody candidates for therapeutic, diagnostic, and research applications.  Watch the webinar replay now: https://lnkd.in/dPmBWuyz   #antibodydiscovery #drugdiscovery #webinar #therapeutics #Carterra #Genovac #ENPICOM

We’re gearing up for PEGS Europe 2024! Christian Giddens and Andrew Goodhead will be on site presenting posters showcasing Carterra’s HT-SPR technology’s role in transforming antibody screening and characterization in the same workflow. From IgG-Fc biologics to tough membrane targets, Carterra’s platforms make it faster and easier to measure binding kinetics and epitope binning for drug candidates, giving scientists powerful insights to increase the speed of therapeutic antibody discovery. Be sure to stop by the poster sessions to learn more about the most recent developments and find out how Carterra can support your drug discovery programs. #HTSPR #LSAXT #biologics #drugdiscovery #PEGSEurope2024 #SPR #labelfree #immunoassay #biotechnology #Carterra

Carterra’s Maria McGresham, PhD and Sr. Applications Scientist, delivered an insightful talk at Vanderbilt University, Center for Structural Biology, where a Carterra LSA-XT was recently installed. She explored high-throughput kinetic screening of Fabs from crude periplasmic extracts, the complexities of bispecific antibody characterization, and many other applications of the LSA-XT. The attendees spent time connecting and sharing ideas during the reception that followed, making it an inspiring and successful event for all involved. Thanks to the Vandy leadership—Charles Sanders, Borden Lacy, and Ben Spiller—for their vision and guidance. #bispecifics #antibodydiscovery #drugdiscovery #HTSPR #kinetics #smallmolecule #vaccine #Vanderbilt #Carterra